Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (281-290 of 894) with videos related to

Pageof 90
Sort By:
Nature Reviews. Nephrology|August 31, 2016
Podocyte-actin dynamics in health and diseaseLuca Perico, Sara Conti, Ariela Benigni, et al.
Expert Opinion on Therapeutic Targets|June 1, 2019
A preclinical overview of emerging therapeutic targets for glomerular diseasesPaola Cassis, Carlamaria Zoja, Luca Perico, et al.
Nature Reviews. Nephrology|September 19, 2018
Maternal and environmental risk factors for neonatal AKI and its long-term consequencesNorberto Perico, David Askenazi, Monica Cortinovis, et al.
Microorganisms|January 13, 2019
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic SyndromeSimona Buelli, Carlamaria Zoja, Giuseppe Remuzzi, et al.
Pflugers Archiv : European Journal of Physiology|September 19, 2009
Angiotensin receptors as determinants of life spanPaola Cassis, Sara Conti, Giuseppe Remuzzi, et al.
Expert Opinion on Emerging Drugs|November 8, 2014
Novel effective drugs for diabetic kidney disease? or not?Giorgio Gentile, Daniela Mastroluca, Piero Ruggenenti, et al.
Nephron|May 18, 2026
Immunosuppressive strategies in kidney xenotransplantation with an emphasis on complement inhibitionFederica Casiraghi, Nadia Azzollini, Giuseppe Remuzzi, et al.
Scientific Reports|February 20, 2026
A scanning electron microscopy-based approach to explore subpodocyte space remodeling in diabetic kidneys of mice and humansSara Conti, Ariela Benigni, Giuseppe Remuzzi, et al.
Nature|February 28, 2014
Stamina therapies: Time to call a haltSilvio Garattini, Giuseppe Remuzzi, Gianluca Vago, et al.
Stem Cell Reviews and Reports|January 13, 2012
Multipotent mesenchymal stromal cell therapy and risk of malignanciesFederica Casiraghi, Giuseppe Remuzzi, Mauro Abbate, et al.
Pageof 90

Showing results (281-290 of 894) with videos related to

Sort By:
Pageof 90
Nature Reviews. Nephrology|August 31, 2016
Podocyte-actin dynamics in health and diseaseLuca Perico, Sara Conti, Ariela Benigni, et al.
Expert Opinion on Therapeutic Targets|June 1, 2019
A preclinical overview of emerging therapeutic targets for glomerular diseasesPaola Cassis, Carlamaria Zoja, Luca Perico, et al.
Nature Reviews. Nephrology|September 19, 2018
Maternal and environmental risk factors for neonatal AKI and its long-term consequencesNorberto Perico, David Askenazi, Monica Cortinovis, et al.
Microorganisms|January 13, 2019
Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic SyndromeSimona Buelli, Carlamaria Zoja, Giuseppe Remuzzi, et al.
Pflugers Archiv : European Journal of Physiology|September 19, 2009
Angiotensin receptors as determinants of life spanPaola Cassis, Sara Conti, Giuseppe Remuzzi, et al.
Expert Opinion on Emerging Drugs|November 8, 2014
Novel effective drugs for diabetic kidney disease? or not?Giorgio Gentile, Daniela Mastroluca, Piero Ruggenenti, et al.
Nephron|May 18, 2026
Immunosuppressive strategies in kidney xenotransplantation with an emphasis on complement inhibitionFederica Casiraghi, Nadia Azzollini, Giuseppe Remuzzi, et al.
Scientific Reports|February 20, 2026
A scanning electron microscopy-based approach to explore subpodocyte space remodeling in diabetic kidneys of mice and humansSara Conti, Ariela Benigni, Giuseppe Remuzzi, et al.
Nature|February 28, 2014
Stamina therapies: Time to call a haltSilvio Garattini, Giuseppe Remuzzi, Gianluca Vago, et al.
Stem Cell Reviews and Reports|January 13, 2012
Multipotent mesenchymal stromal cell therapy and risk of malignanciesFederica Casiraghi, Giuseppe Remuzzi, Mauro Abbate, et al.
Pageof 90